217480 — SD Biotechnologies Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesMicro Cap

Annual balance sheet for SD Biotechnologies Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16,251	15,494	27,010	19,566	14,900
Net Total Accounts Receivable
Net Total Receivables	16,748	6,123	2,953	2,137	2,878
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	80,415	44,051	59,137	45,688	43,316
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	59,260	48,284	15,904	14,624	3,715
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	146,467	96,439	76,123	60,688	48,002
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	84,730	77,840	30,919	30,766	17,419
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	100,510	93,343	32,117	31,576	18,619
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	45,957	3,096	44,005	29,111	29,383
Total Liabilities & Shareholders' Equity	146,467	96,439	76,123	60,688	48,002
Total Common Shares Outstanding